Evidence map›Paper›PMID 41630038›Full record

ArticleRetrovirology2026

Investigation of the expression level of human endogenous retrovirus E env transcript in cervical cancer.

Shaghayegh Jahanshahi, Rahim Soleimani-Jelodar, Somayeh Jalilvand, Zabihollah Shoja, Mohammad Farahmand, Arash Arashkia, Sayed Mahdi Marashi

Abstract read
In one paragraph

Article in Retrovirology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shaghayegh Jahanshahi *Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Rahim Soleimani-Jelodar *Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Somayeh JalilvandDepartment of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Zabihollah ShojaDepartment of Molecular Virology, Pasteur Institute of Iran, Tehran, Iran.
Mohammad FarahmandPediatric Infectious Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Arash ArashkiaDepartment of Molecular Virology, Pasteur Institute of Iran, Tehran, Iran.
Sayed Mahdi MarashiDepartment of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. m-marashi@tums.ac.ir.

Funding

Tehran University of Medical Sciences and Health Services 66589
6 · The paper itself

Abstract

Although HPV infection is obligatory for almost all cases of cervical cancer (CC), other risk factors can promote the progression of cervical cancer. In this context, the expression of human endogenous retroviruses (HERVs) in the development of CC has been investigated. In this study, the expression status of HERV-E env transcripts was analyzed in 111 cervical biopsies, including 35 cervical cancer samples, 20 precancerous lesions, and 56 normal samples. Real-time PCR with specific primers was used to quantify the relative expression of HERV-E env, HPV 16 and 18 E6/E7 genes, and GAPDH as a normalization control. Our results indicated an increase in the expression of HERV-E env, and the difference was statistically significant in the cancer group compared to the precancerous group (1.5-fold change) (P = 0.031). In HPV 16 or 18-infected patients, a higher mean value of HERV-E env mRNA was also found in the cancer group than in the precancerous group. ROC curve analysis showed a significant difference in env expression between precancerous and cancerous lesions in all patients analyzed (P = 0.015) and in a group of patients infected with HPV 16 or 18 genotypes (P = 0.023). In addition, there was a positive correlation between the higher expression of HERV-E env mRNA with E7 (R = 0.34, P = 0.016) and age (R = 0.35, p = 0.016) in HPV 16-infected patients. In conclusion, our study found a possible association between HERV-E env expression and cervical cancer, as HERV-E is actively transcribed during the progression of cervical lesions. Future studies on the potential interaction of HERV-E env with HPV 16 E7 oncoprotein are likely to elucidate common signaling pathways in the progression of cervical cancer and other HPV-related malignancies.

Indexed as

Endogenous RetrovirusesGene Products, envUterine Cervical NeoplasmsAdultAgedDNA-Binding ProteinsFemaleHuman papillomavirus 16Human papillomavirus 18HumansMiddle AgedOncogene Proteins, ViralPapillomavirus E7 ProteinsPapillomavirus InfectionsReal-Time Polymerase Chain ReactionDNA-Binding ProteinsE6 protein, Human papillomavirus type 18Gene Products, envoncogene protein E7, Human papillomavirus type 16Oncogene Proteins, ViralPapillomavirus E7 ProteinsCervical cancerHERV-E env mRNAHuman papillomavirus

Identifiers

PMID41630038
PMCPMC12952192

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.